Login / Signup

Nanoscale pathogens treated with nanomaterial-like peptides: a platform technology appropriate for future pandemics.

Alaa F NahhasAlrayan F NahhasThomas Jay Webster
Published in: Nanomedicine (London, England) (2021)
Viral infections are historically very difficult to treat. Although imperfect and time-consuming to develop, we do have some conventional vaccine and therapeutic approaches to stop viral spreading. Most importantly, all of this takes significant time while viruses continue to wreak havoc on our healthcare system. Furthermore, viral infections are accompanied by a weakened immune system which is often overlooked in antiviral drug strategies and requires additional drug development. In this review, for the first time, we touch on some promising alternative approaches to treat viral infections, specifically those focused on the use of platform nanomaterials with antiviral peptides. In doing so, this review presents a timely discussion of how we need to change our old way of treating viruses into one that can quickly meet the demands of COVID-19, as well as future pandemic-causing viruses, which will come.
Keyphrases
  • sars cov
  • coronavirus disease
  • respiratory syndrome coronavirus
  • high throughput
  • current status
  • high resolution
  • amino acid
  • newly diagnosed
  • drug induced
  • single cell
  • multidrug resistant